Cargando…
Noninvasive approaches to detect methylation-based markers to monitor gliomas
In this review, we summarize the current approaches used to detect glioma tissue-derived DNA methylation markers in liquid biopsy specimens with the aim to diagnose, prognosticate and potentially track treatment response and evolution of patients with gliomas.
Autores principales: | Noushmehr, Houtan, Herrgott, Grayson, Morosini, Natalia S, Castro, Ana Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650474/ https://www.ncbi.nlm.nih.gov/pubmed/36380867 http://dx.doi.org/10.1093/noajnl/vdac021 |
Ejemplares similares
-
ODP653 DNA Methylation Markers Detected in Liquid Biopsy Specimens Differentiate Pituitary Neuroendocrine Tumors from Other Sellar and CNS Diseases
por: Castro, Ana Valeria, et al.
Publicado: (2022) -
OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021) -
OTME-5. Meningioma liquid biopsy specimens exhibit contrasting immune-cell landscapes across methylation-subtypes and estimated recurrence risk subgroups
por: Herrgott, Grayson, et al.
Publicado: (2021) -
TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021) -
Unmet need for liquid biomarkers and the Brain-Liquid Biopsy Consortium
por: Short, Susan C, et al.
Publicado: (2022)